Novartis AG - Accounts Payable

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accounts-Payable" stands at 4.56 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Accounts Payable" stands at 4.56 Billion USD. This represents an increase of 1.09 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.45 percent compared to the value the year prior.
The 1 year change in percent is 11.45.
The 3 year change in percent is -2.94.
The 5 year change in percent is -3.19.
The 10 year change in percent is -5.60.

The Serie's long term average value is 4.88 Billion United States Dollars. It's latest available value, on 09/30/2025, is 6.74 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +17.70%.
The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is -25.91%.